Feasibility of palliating recurrent gynecological tumors with MRGHIFU: comparison of symptom, quality-of-life, and imaging response in intra and extra-pelvic disease.

Georgios ImseehSharon L GilesAlexandra TaylorMatthew R D BrownIan RivensRichard Gordon-WilliamsGail Ter Haar Nandita M deSouza

Published in: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group (2021)

MRgHIFU treatments can be delivered safely to patients with recurrent gynecological tumors. Extra-pelvic tumors responded better than intra-pelvic tumors and showed immediate swelling and reduction in perfused volume by day 30.

Keyphrases

rectal cancer
photodynamic therapy
fluorescence imaging
patient reported